News about Drug Discovery & Development

Viatris Signs Licensing Deal with Lexicon Pharmaceuticals for Sotagliflozin

This licensing agreement leverages Viatris' expertise in cardiovascular diseases and its Global Healthcare Gateway, which offers partners ready access to more markets and patients worldwide through the company's unique global infrastructure and expertise.

Drug Discovery & Development | 18/10/2024 | By Aishwarya |  733

Kvantify Launches New Computational Method for Drug Discovery

The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.

Drug Discovery & Development | 14/10/2024 | By Aishwarya |  412

Lipocine Signs Supply and Distribution Deal with Pharmalink to Commercialize TLANDO

Under the terms of the agreement, Lipocine received an upfront payment from Pharmalink and, upon Marketing Authorizations (MA) in individual GCC countries, Lipocine will provide TLANDO drug products to Pharmalink at an agreed transfer price.

Drug Discovery & Development | 11/10/2024 | By Aishwarya |  288

Alkem Laboratories Signs Licensing Deal with Sonnet BioTherapeutics

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet and enable global and India regulatory filings.

Drug Discovery & Development | 10/10/2024 | By Aishwarya |  522

Sun Pharma Signs Global Exclusive Deal with Philogen for Commercializing FIBROMUN

Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.

Drug Discovery & Development | 01/10/2024 | By Aishwarya |  549

Alembic Gets FDA Approval for Paliperidone Extended-Release Tablets

Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia and it is also indicated for treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.

Drug Discovery & Development | 30/09/2024 | By Aishwarya |  555

AstraZeneca India Secures CDSCO Approval for Durvalumab

AstraZeneca Pharma India has been granted permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO).

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  594

Takara Bio Europe Rolls Out New NGS Profiling System and Chemistries

The Shasta Total RNA-Seq Kit is the first high-throughput single-cell total RNA profiling kit to offer full gene body coverage of up to 100,000 cells per run.

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  437

Heron Therapeutics Gets FDA Approval for ZYNRELEF VAN

The VAN will replace the current vented vial spike and has the potential to simplify aseptic preparation, while also significantly reducing ZYNRELEF's withdrawal time down to between twenty and forty-five seconds.

Drug Discovery & Development | 26/09/2024 | By Aishwarya |  642

Lupin and Takeda to Commercialize Vonoprazan in India

Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India.

Drug Discovery & Development | 19/09/2024 | By Aishwarya |  951